Display options
Cite
Xu P, Wang H, Kayoumu A, et al. Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice. Nutr Metab (Lond). 2015;12:58doi: 10.1186/s12986-015-0054-x.
Xu, P., Wang, H., Kayoumu, A., Wang, M., Huang, W., & Liu, G. (2015). Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice. Nutrition & metabolism, 1258. https://doi.org/10.1186/s12986-015-0054-x
Xu, Pengfei, et al. "Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice." Nutrition & metabolism vol. 12 (2015): 58. doi: https://doi.org/10.1186/s12986-015-0054-x
Xu P, Wang H, Kayoumu A, Wang M, Huang W, Liu G. Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice. Nutr Metab (Lond). 2015 Dec 18;12:58. doi: 10.1186/s12986-015-0054-x. eCollection 2015. PMID: 26690553; PMCID: PMC4683947.
Copy Download .nbib Format: NLM
Share it on

Nutr Metab (Lond). 2015 Dec 18;12:58. doi: 10.1186/s12986-015-0054-x. eCollection 2015.

Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice.

Nutrition & metabolism

Pengfei Xu, Huan Wang, Abudurexiti Kayoumu, Mengyu Wang, Wei Huang, George Liu

Affiliations

  1. Institute of Cardiovascular Sciences, Key Laboratory of Molecular Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center, 38, XueYuan Road, HaiDian District, Beijing, 100191 People's Republic of China.

PMID: 26690553 PMCID: PMC4683947 DOI: 10.1186/s12986-015-0054-x

Abstract

BACKGROUND: N-3 polyunsaturated fatty acids (n-3 PUFAs), in particular eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been shown to effectively improve hepatic steatosis and insulin resistance caused by obesity. Lipodystrophy could also develop insulin resistance and hepatic steatosis. However, the effect of supplemental DHA/EPA to hepatic steatosis caused by lipodystrophy is unknown. In this study, we investigated whether a diet rich in n-3 PUFAs could ameliorate severe steatosis in lipoatrophic seipin gene knockout (SKO) mice.

METHODS: Eight-week-old C57BL/6 J WT and SKO mice were fed with normal chow diet (NC), or 2 % DHA/EPA (3:1) diet for 12 weeks. Total cholesterol (TC) and triglycerides (TG) in plasma and liver, plasma high density lipoprotein-cholesterol (HDL-C), glucose (Glu), insulin, leptin and adiponectin levels were measured. Gene regulations and protein levels were investigated using quantitative PCR and western blot in liver.

RESULTS: We found that the DHA/EPA diet protected against hepatic steatosis effectively in SKO mice morphologically. Hepatic TG content was decreased about 40 % (p < 0.05) in SKO mice fed with the DHA/EPA diet compared to chow fed SKO controls. Glucose and insulin tolerance were also improved significantly in SKO mice with DHA/EPA diet. In analyzing hepatic gene expression pattern it was found that TG synthesis related genes, such as carbohydrate response element binding protein (ChREBP), stearoyl-CoA desaturase 1 (SCD1) and fatty acid synthase (Fas) were upregulated in SKO mice compared to WT mice but were significantly decreased in SKO mice on DHA/EPA diet. Fatty acid β-oxidation related genes, on the other hand, such as peroxisome proliferator-activated receptor α (PPARα), carnitine palmitoyltransferase (CPT) and acyl-CoA oxidase 1 (ACOX1) were elevated in both WT and SKO groups on DHA/EPA diets. The protein levels of PPARα, SCD1, CPT1α, Insulin receptor substrate 1 (IRS1) and ratio of p-AKT to AKT showed the same tendency as the result of genes expressions.

CONCLUSIONS: The results suggest that n-3 PUFAs rich diet ameliorates lipodystrophy-induced hepatic steatosis through reducing TG synthesis, improving insulin resistance and enhancing β-oxidation in SKO mice.

Keywords: Congenital generalized lipodystrophy; De novo lipogenesis; Docosahexaenoic acid (DHA); Eicosapentaenoic acid (EPA); Hepatic steatosis; Insulin resistance; Seipin; n-3 polyunsaturated fatty acids; β-oxidation

References

  1. Metab Syndr Relat Disord. 2007 Dec;5(4):315-22 - PubMed
  2. J Nutr. 2013 Mar;143(3):315-23 - PubMed
  3. Biochim Biophys Acta. 2011 Dec;1811(12):1194-200 - PubMed
  4. Hepatology. 2014 Feb;59(2):713-23 - PubMed
  5. Annu Rev Med. 2006;57:297-311 - PubMed
  6. PLoS One. 2015 Oct 06;10(10):e0138889 - PubMed
  7. Endocrinology. 2014 Nov;155(11):4215-25 - PubMed
  8. PLoS One. 2015 Jul 10;10(7):e0132472 - PubMed
  9. Nutrients. 2015 Mar 05;7(3):1644-56 - PubMed
  10. J Lipid Res. 1993 Jan;34(1):13-22 - PubMed
  11. Lipids. 2014 May;49(5):431-44 - PubMed
  12. Trends Mol Med. 2008 Feb;14(2):72-81 - PubMed
  13. Hepatology. 2003 Dec;38(6):1529-39 - PubMed
  14. Nat Med. 1998 Nov;4(11):1329-33 - PubMed
  15. Food Funct. 2011 Nov;2(11):644-8 - PubMed
  16. Pharmacol Rev. 2008 Sep;60(3):311-57 - PubMed
  17. Hum Mol Genet. 2011 Aug 1;20(15):3022-30 - PubMed
  18. J Lipid Res. 1988 Nov;29(11):1417-26 - PubMed
  19. Semin Liver Dis. 2012 May;32(2):158-66 - PubMed
  20. PLoS One. 2014 Dec 26;9(12):e114942 - PubMed
  21. Crit Rev Biochem Mol Biol. 2010 Jun;45(3):199-214 - PubMed
  22. Biosci Rep. 2014 Oct 02;34(5):null - PubMed
  23. Diabetologia. 2013 Aug;56(8):1813-25 - PubMed
  24. World J Hepatol. 2015 May 18;7(8):1012-9 - PubMed
  25. BMJ. 2014 Jul 29;349:g4596 - PubMed
  26. Gastroenterology. 2012 Jun;142(7):1592-609 - PubMed
  27. J Biol Chem. 1957 May;226(1):497-509 - PubMed
  28. Biochim Biophys Acta. 2009 Nov;1792(11):1080-6 - PubMed
  29. J Clin Invest. 2005 Oct;115(10):2843-54 - PubMed
  30. FASEB J. 2009 Jun;23(6):1946-57 - PubMed
  31. Biochem Biophys Res Commun. 2015 May 29;461(2):206-10 - PubMed

Publication Types